Cantú syndrome (OMIM 239850) or hypertrichotic osteochondrodysplasia, first described by Cantú et al. [1982] , is characterized by generalized congenital hypertrichosis, neonatal macrosomia, distinctive coarse facial features, cardiomegaly, and skeletal abnormalities [Cantú et al., 1982] . The facial appearance resembles acromegaloid syndromes or storage disorders [Harakalova et al., 2012; van Bon et al., 2012] . To date, about 50 cases with Cantú syndrome have been reported, and heterozygous pathogenic variants in the ABCC9 or the KCNJ8 genes have been found in 80% of the cases [van Bon et al., 2012; Czeschik et al., 2013] . Cantú syndrome is caused by gain-of-function mutations in the genes encoding the pore-forming (Kir6.1 , KCNJ8 ) and regulatory (SUR2, ABCC9 ) subunits of the predominately cardiovascular isoforms of the K ATP sensitive channel [van Bon et al., 2012] .
Two more entities with overlapping clinical features have also been described: acromegaloid facial appearance syndrome (AFA; OMIM 102150) and hypertrichosis with acromegaloid facial features (HAFF; OMIM 135400) [Dallapiccola et al., 1992; Czeschik et al., 2013] . The ABCC9 gene has been recognized as the cause of Cantú syndrome. In suspected AFA and HAFF syndromes, even if they cannot be clearly distinguished clinically from Cantú syndrome, mutation analysis of the ABCC9 gene should be carried out to confirm the diagnosis as similar mutations can give rise to dissimilar phenotypes [Czeschik et al., 2013; Afifi et al., 2016] .
In this study, we present a girl with clinical features of Cantú syndrome, who carries a mutation in the ABCC9 gene along with additional previously unreported findings such as absent ovaries and a hypoplastic uterus. This could be an expansion of the phenotype and not attributed to mutations in other genes important for ovarian formation and function.
Case Report
The female patient is the third child of healthy nonconsanguineous parents of Greek descent. The pregnancy was complicated by polyhydramnios, and the infant was born prematurely by normal delivery at 35 weeks of gestation. At birth, the infant displayed macrosomia (weight: 3,650 g [97th centile], length: 49 cm [90th centile], head circumference: 34.5 cm [97th centile]). At 14 days, she was admitted to a hospital due to hypotonia, feeding difficulties, and coarse facial characteristics. Generalized hypertrichosis, especially at the sacral region, was also observed.
The facial gestalt included: macrocephaly, thick and bushy eyebrows, epicanthal folds, a broad nasal bridge, a bulbus nose, a long philtrum, thick lips (particularly the lower lip), a short neck, and low-set ears ( Fig. 1 A) . Subsequent metabolic testing for mucopolysaccharidoses and lysosomal storage diseases was negative. A con- 208 genital infection panel work-up and thyroid function testing were also normal. Cardiac evaluation due to a heart murmur by ultrasound documented mild mitral regurgitation, a small patent ductus arteriosus, and patent foramen ovale. Furosemide treatment was initiated. Neurological evaluation revealed hypotonia. Brain ultrasound showed 2 small cysts of the choroid plexus with no clinical significance. The infant was reevaluated regularly, and at 12 months, hypotonia showed a slight improvement as well as her heart problem. However, the generalized hypertrichosis and coarse facial features were still evident. At the age of 4 years, the clinical examination at the Clinical Genetic Unit showed borderline performance, macrocephaly (head circumference: 53 cm [90th centile]), while the rest of the somatometric measurements were within normal range (weight: 18 kg [25-50th centile], height: 110 cm [50th centile]). Our patient had a wide mouth, with continuous drooling and a protruding tongue with 2 frenulae on the upper and lower lips. The chest was markedly narrow with everted and supernumerary nipples. Joint laxity, deep palmar and plantar creases were observed. Hypoplasia was found only on the second, third, and fourth left toe phalanges ( Fig. 1 B) . Generalized hypertrichosis was obvious ( Fig. 2 A-C) . The external genitalia were normal. Cardiac reexamination by ultrasound was normal.
A second brain and lumbosacral MRI revealed no abnormalities. Ophthalmologic and auditory assessments were normal. The uterus was hypoplastic, but no ovaries were depicted by an ultrasound, and this was confirmed by an abdominal MRI in a 1.5 Tesla GE scanner, before and after intravenous administration of contrast agent ( Fig.  3 A-C) . Hematologic, biochemical, and endocrine testing such as follicle stimulating hormone: 1.37 mIU/mL (normal values: <3.80), prolactin: 30.51 ng/mL (normal values: 5-20), estradiol, luteinizing hormone, testosterone, DHEA-S, and 17-OH progesterone were normal. Thyroid function, growth hormone, insulin-like growth factor, parathyroid hormone as well as vitamin D were also all normal ( Table 1 ) . A radiologic evaluation of the long bones was normal, and the bone age of the right hand using the Greulich-Pyle scale showed that the skeletal maturation was 1 year behind.
Methods
Chromosomal analysis by G-banding technique revealed a normal female karyotype (46,XX).
A genomic DNA sample was extracted from the peripheral blood of both the patient and her parents following standard procedures. A sequencing analysis (Sanger sequencing) of the ABCC9 gene (NCBI: NM_02097.3) was performed using a standard methodology (Institute for Human Genetics, University Clinic, Essen, Germany).
Molecular analysis of the patient also included QF-PCR amplification (Devyser) and capillary electrophoresis on an AB13500 Further investigation with aCGH was performed by hybridizing the sample against a male human reference commercial DNA sample (Promega Biotech) using an aCGH platform that included 60,000 oligonucleotides distributed across the entire genome (Agilent Technologies). For the majority of the genome, the average genomic power of resolution of this analysis was 200 kb.
Results
The affected transcript was NM_005691.3 (ABCC9v001): c.3460C>T (p.Arg1154Trp) that resulted in the abnormal protein NM-005691.3 (ABCC9_1001): p.Arg1154Trp
(http://humgenprojects.lumc.nl/trac/ mutlyser/wiki/NameChecker). This known missense mutation is located in exon 27 of the ABCC9 gene in a heterozygous state. The parental DNA molecular analysis was normal.
No amplicons from the Y chromosome and especially the SRY gene were detected. The marker ratio of the informative pseudoautosomal XY chromosome STR markers (XY2 and XY3) confirmed the absence of the Y chromosome and a normal female sex constitution. The aCGH analysis was normal.
Discussion
This study describes a sporadic case of a girl with Cantú syndrome. Cantú syndrome has been considered as a new member of potassium channelopathies [van Bon et al., 2012] . The syndrome has been attributed to mutated ABCC9 or KCNJ8 genes as the underlying causes. They are both located in the 12p12.1 gene cluster and encode the SUR2 and Kir6.1 subunits of ATP-dependent potassium channels (K ATP channel) [van Bon et al., 2012] . Alternative RNA splicing of the terminal exon of the ABCC9 gene produces a SUR2A isoform that is expressed in cardiac and skeletal muscles, while the SUR2B isoform is mainly expressed in smooth muscles. The biological role of ABCC9 is protective against ischemic stress in the heart or skeletal muscle and regulates the vasomotor tone when energy supplies are low [Bryan et al., 2007; Flagg et al., 2010; Harakalova et al., 2012] .
In Cantú syndrome, gain-of-function mutations in the Kir6.1 and SUR2 subunits of K ATP channels could explain the presence of cardiac hypertrophy, hypertrichosis and edema secondary to the vasodilating effect on smooth muscles [Bienengraeber et al., 2004; Grange et al., 2006; Li et al., 2013] . Loss-of-function mutations in the ABCC9 gene have been associated with an atrial fibrillation phenotype in one patient [Olson et al., 2007; Scurr et al., 2011] , idiopathic dilated cardiomyopathy [Bienengraeber et al., 2004; Grange et al., 2006] , and conduction abnormalities such as Brugada and early repolarization syndromes [Hu et al., 2014] .
However, 28 of the 35 patients with Cantú syndrome reported so far who have undergone an ABCC9 gene molecular analysis to date have been found to carry a heterozygous pathogenic variant with a gain-of-function effect at the protein level [Harakalova et al., 2012; van Bon et al., 2012] . Our patient carries a de novo c.3460C>T (R1154W) variant which is associated with the full phenotype of Cantú syndrome. This arginine-to-tryptophan substitution, in a highly conserved residue, in the second type 1 transmembrane domain of the ABCC9 protein which was not found in 5,000 exomes, indicated the pathogenic nature of the generating protein [van Bon et al., 2012] . The same mutation has been identified in an Egyptian girl with HAFF by Afifi et al. [2016] . The atypical and clinically distinct conditions of AFA and HAFF may belong to the milder end of the ABCC9 phenotype spectrum [Kini and Clayton-Smith, 2004; Czeschik et al., 2013] .
Despite identification of the hotspot ABCC9 variant, our patient demonstrated only mild cardiac involvement, with no pericardial effusion or lymphedema so far. However, data from medical literature suggest that cardiac hypertrophy and skeletal abnormalities are not always present at an early age due to the progressive nature of the disorder [Scurr et al., 2011; Hiraki et al., 2013] . The most common skeletal changes are calvarial thickness, wide ribs, platyspondyly, ischiopubic hypoplasia, bilateral coxa valga, and wide metaphyses. In our patient, a radiographic skeletal survey showed only wide ribs. Hypoplasia of only the second, third and fourth left toe distal phalanges was noted. This was attributed to annular constricting amniotic bands due to amnion rupture and small strands of amnion which constrict parts of the limbs and can result in deformity.
The important finding in our patient was the absence of the ovaries and hypoplastic uterus. So far, there are no reports of bilateral congenital ovarian agenesis in Cantú syndrome. In our patient, there is no family history of ovarian agenesis. Other causes of ovarian agenesis were ruled out since we had a female karyotype (46,XX), negative SRY testing, and a normal aCGH analysis. Therefore, the abnormal internal genitalia could represent an expansion of the Cantú phenotype and not be due to mutations or variations in other genes which could influence ovarian development.
Our findings further contribute to the delineation of the clinical phenotype of Cantú syndrome. Additional reports regarding urogenital and gonadal abnormalities with the ABCC9 gene clinical spectrum are required in the future. Studies of such rare diseases could lead to a better understanding of the pathophysiology of ABCC9 -related syndromes. Appropriate genetic counseling and prenatal diagnosis for these patients and their families must also be stressed. We recommend regular follow-ups for our patient, especially for cardiac implications and endocrine manifestations as these symptoms of Cantú syndrome progress with age.
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